Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Bispebjerg Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT01349361
First received: May 5, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)